QBM-076

N/A

Report date: 2024/01/10 15:11:31

NME

Base Information

Drug NameQBM-076

Drug Alias NameQBM-076

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionC-X-C motif chemokine receptor 2 antagonists

TargetsC-X-C motif chemokine receptor 2

Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesRomaniaGermany +[4]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic Obstructive

ATC CodeN/A